We are live on ! Find out more
LLY icon

Eli Lilly

1,117 hedge funds and large institutions have $61B invested in Eli Lilly in 2015 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 378 increasing their positions, 463 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $458M | Put options by funds: $261M

23% more funds holding in top 10

Funds holding in top 10: 3543 (+8)

5% more capital invested

Capital invested by funds: $58B → $61B (+$3.09B)

1% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 75

0.13% more ownership

Funds ownership: 75.64%75.78% (+0.13%)

1% less funds holding

Funds holding: 1,1291,117 (-12)

18% less repeat investments, than reductions

Existing positions increased: 378 | Existing positions reduced: 463

Holders
1,117
Holders Change
-12
Holders Change %
-1.06%
% of All Funds
29.76%
Holding in Top 10
43
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+22.86%
% of All Funds
1.15%
New
76
Increased
378
Reduced
463
Closed
75
Calls
$458M
Puts
$261M
Net Calls
+$197M
Net Calls Change
+$332M

LLY Hedge Fund Activity: Q1 2015 in Review

1,117 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2015, worth a combined $61B — up 5.3% from $58B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new LLY positions and 75 closed out — a net gain of 1 holder — while 378 added to existing stakes and 463 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $254M.

  • 1,117 institutional investors held Eli Lilly (LLY) as of Q1 2015, down from 1,129 in Q4 2014.
  • Funds reported $61B of Eli Lilly stock for Q1 2015, up 5.3% quarter-over-quarter.
  • 76 funds opened new Eli Lilly positions in Q1 2015 and 75 closed out, a net change of +1 holder.
  • The largest Eli Lilly buyer in Q1 2015 was Janus Henderson Investors US, an estimated $352M added.
  • The largest Eli Lilly seller in Q1 2015 was T. Rowe Price Associates, an estimated $254M sold.

Based on aggregated 13F filings for Q1 2015.